# 바이오스페이스 일일 뉴스 리포트 - 2025년 09월 03일


## 주요 헤드라인

1. **Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/vertex-enlaza-declare-war-on-autoimmune-disease-in-potential-2b-pact>

2. **Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/vertex-enlaza-declare-war-on-autoimmune-disease-in-potential-2b-pact>

3. **Servier Commits up to $530M Into Eye Cancer Deal With IDEAYA (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/servier-commits-up-to-530m-into-eye-cancer-deal-with-ideaya>

4. **Servier Commits up to $530M Into Eye Cancer Deal With IDEAYA (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/servier-commits-up-to-530m-into-eye-cancer-deal-with-ideaya>

5. **Arrowhead Nabs up to $2B Novartis Commitment for siRNA Parkinson’s Program (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/arrowhead-nabs-up-to-2b-novartis-commitment-for-sirna-parkinsons-program>

6. **Roche Makes Preclinical IBD Play in $420M+ OMass Pact (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/roche-makes-preclinical-ibd-play-in-420m-omass-pact>

7. **Novo’s Wegovy Cuts Cardio Risk by 57% Versus Tirzepatide (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/novos-wegovy-cuts-cardio-risk-by-57-versus-tirzepatide>


---
*2025년 09월 03일 바이오스페이스 뉴스 피드에서 생성된 리포트*